trial · primary record
JNJ-79635322
Relapsed or Refractory Multiple Myeloma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 180 |
| Primary completion | 2030-11-15 |
| Primary endpoint | Part 1: Number of Participants with Dose-limiting Toxicity (DLT) |
| Registry ID | NCT05652335 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:49.948Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05652335
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Jnj-79635322 · compound